8% for absence of CMV detection in BAL. HSV DNA detection in NPS, especially if detected within 8 days after transplantation, was associated with 90-day mortality. In conclusion, detection of herpesviruses in the RT was clinically relevant and frequent, despite antiviral prophylaxis.”
“Purpose: To assess the knowledge and awareness of pregnant women regarding the use of sulfadoxine-pyrimethamine (SP) for intermittent preventive therapy
(IPT) and artemether-lumefantrine (ALu) for treatment of malaria during pregnancy.
Methods: The study was conducted in Rufiji district, southern Tanzania from March 2011 to September learn more 2011. Four hundred and seventy (470) pregnant women in their second and third trimesters were interviewed when attending antenatal clinics at the selected hospitals, health centers and dispensaries. Focus group discussions (FGDs) were also conducted with 46 pregnant women at the health facilities in the district.
Results: More than
half (54.3 %) of pregnant women did not know if SP it was used for IPT. Most women (76.6 %) did not know the use of SP for IPT in relationship with gestation age. Overall, the results show that most women had very low knowledge about the use of SP for IPT. Forty three (9.1 %) pregnant women reported to have had malaria during their current pregnancies. The antimalarials reported to be used by pregnant women were quinine 18(42.9 %), SP (23.8 %), ALu (21.4%) and sulphamethoxyprazine-pyrimethamine (2.4%). Irrespective of the gestation age of pregnancy, almost all (98.3 %) pregnant women perceived ALu as unsafe drug to be used during pregnancy.
Conclusion: Most pregnant women had minimum IDN-6556 knowledge about the use and benefits of SP for IPT and ALu for treatment of malaria during pregnancy. Some erroneous beliefs about the safety of ALu during pregnancy were also identified among pregnant women. For effective QNZ mouse implementation of IPT policy
and treatment of malaria during pregnancy, pregnant women should be sensitized and educated on the use and benefits of antimalarial drugs.”
“In the present study, the antioxidant potencies of ethanolic extract and its derived phytochemicals from the root of Acacia confusa, the indigenous Taiwanese species, were investigated and reported for the first time. Among all the soluble fractions of ethanolic extract, the EtOAc soluble fraction exhibited the best antioxidant activity. The bioassay-guided fractionation was carried out and yielded 9 potent antioxidative phytochemicals from EtOAc fraction. Among them, okanin (9) exhibited the lowest IC50 DPPH radical and superoxide anion radical scavenging activity values and the highest TEAC and reducing power activity. Besides, melacacidin (3) was the most abundant antioxidant compound in A. confusa root extract with an absolute content of 109.1 mg/g of crude extract. The structure-activity relationships of antioxidant flavonoids isolated from A.